Embla Medical hfOSSFF 92 Gross Margin % is 61.56% as of Mar. 2026, which is 1% below its 10-year median of 62.47. GuruFocus rates OSSFF with a GF Score™ of 92/100 and a GF Value™ of $5.49. The stock has 2 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Embla Medical hf ranks better than 65.47% on this metric.
The historical rank and industry rank for Embla Medical hf's Gross Margin % or its related term are showing as below:
OSSFF'
s Gross Margin % Range Over the Past 10 Years
Min: 61.19 Med: 62.47 Max: 63.92
Current: 61.97
During the past 13 years, the highestGross Margin % of Embla Medical hf was 63.92%. The lowest was 61.19%. And the median was 62.47%.
OSSFF's Gross Margin % is ranked better than 65.47% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs OSSFF: 61.97
Embla Medical hf had a gross margin of 61.56% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Embla Medical hf was -0.10% per year.
Embla Medical hf (OTCPK:OSSFF) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Embla Medical hf had a gross margin of 61.56% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Embla Medical hf Gross Margin % Related Terms
Embla Medical hf Gross Margin % Historical Data
* Premium members only.
The historical data trend for Embla Medical hf's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Embla Medical hf's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Embla Medical hf Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Embla Medical hf's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Embla Medical hf (OSSFF) has a Gross Margin % of 61.56% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Embla Medical hf and its competitors. This is near median its historical median of 62.47. Over the past decade, Embla Medical hf's Gross Margin % has ranged from 61.19 to 63.92. According to the industry distribution chart, Embla Medical hf ranks #278 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 34.5%.
Is Embla Medical hf's Gross Margin % too high?
Embla Medical hf's current Gross Margin % of 61.56% is near median its 10-year median of 62.47. Over the past 10 years, this metric has ranged from a low of 61.19 to a high of 63.92. The Medical Devices & Instruments industry median Gross Margin % is 52.07. Embla Medical hf's value of 61.56% is 18.2% above this industry median. Based on the distribution chart, Embla Medical hf ranks #278 out of 805 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Embla Medical hf has a GF Score™ of 92/100, reflecting its overall financial health beyond just this single metric.
How does Embla Medical hf's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Embla Medical hf ranks #278 out of 805 companies for Gross Margin %. This puts Embla Medical hf in the upper half of its industry. The industry median Gross Margin % is 52.07. Embla Medical hf's value of 61.56% is 18.2% above this benchmark. Historically, Embla Medical hf's own Gross Margin % has ranged from 61.19 to 63.92 over the past decade. While the company's 10-year median is 62.47 vs. the industry median of 52.07, Embla Medical hf has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Embla Medical hf's current Gross Margin % of 61.56% is 18.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Embla Medical hf and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Embla Medical hf's current Gross Margin % is 61.56%, which is near median its own 10-year median of 62.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embla Medical hf stock overvalued right now?
Embla Medical hf (OSSFF) has a current Gross Margin % of 61.56%. The stock's GF Value™ is $5.49, compared to a current price of $4.15 — trading 24.4% below its estimated fair value. The current Gross Margin % is 61.56%, which is near median its 10-year median of 62.47 and 18.2% above the Medical Devices & Instruments industry median of 52.07. Embla Medical hf's overall GF Score™ is 92/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Embla Medical hf (OSSFF), the current Gross Margin % is 61.56% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Embla Medical hf (OSSFF) Overvalued in 2026?
Based on GuruFocus' analysis, Embla Medical hf stock appears to be undervalued.
The current stock price of $4.15 is trading 24.4% below its estimated GF Value™ of $5.49.
Key valuation signals for OSSFF:
Gross Margin %: 61.56% (near median its 10-year median of 62.47)
GF Value™: $5.49 vs. price of $4.15 (24.4% below fair value)
Industry Position: 18.2% above the Medical Devices & Instruments median (#278 of 805)
No single metric tells the full story. See the OSSFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.
92GF Score
Get the complete analysis for OSSFF
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSSFF has been successfully added to your 
